Works matching IS 03618609 AND DT 2014 AND VI 89 AND IP 4

Results: 22
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Azacitidine in untreated acute myeloid leukemia: A report on 149 patients.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 410, doi. 10.1002/ajh.23654
    By:
    • Thépot, Sylvain;
    • Itzykson, Raphael;
    • Seegers, Valerie;
    • Recher, Christian;
    • Raffoux, Emmanuel;
    • Quesnel, Bruno;
    • Delaunay, Jacques;
    • Cluzeau, Thomas;
    • Marfaing Koka, Anne;
    • Stamatoullas, Aspasia;
    • Chaury, Marie-Pierre;
    • Dartigeas, Caroline;
    • Cheze, Stéphane;
    • Banos, Anne;
    • Morel, Pierre;
    • Plantier, Isabelle;
    • Taksin, Anne-Laure;
    • Marolleau, Jean Pierre;
    • Pautas, Cecile;
    • Thomas, Xavier
    Publication type:
    Article
    10
    11

    Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 385, doi. 10.1002/ajh.23649
    By:
    • Fertrin, Kleber Yotsumoto;
    • Lanaro, Carolina;
    • Franco-Penteado, Carla Fernanda;
    • Albuquerque, Dulcinéia Martins;
    • Mello, Mariana Rezende Bandeira;
    • Pallis, Flávia Rubia;
    • Bezerra, Marcos André Cavalcanti;
    • Hatzlhofer, Betania Lucena Domingues;
    • Olbina, Gordana;
    • Olalla Saad, Sara Terezinha;
    • Silva Araújo, Aderson;
    • Westerman, Mark;
    • Costa, Fernando Ferreira
    Publication type:
    Article
    12

    Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 349, doi. 10.1002/ajh.23639
    By:
    • Lazaryan, Aleksandr;
    • Hussein, Mohamad A.;
    • Reu, Frederic J.;
    • Faiman, Beth;
    • Habecker, Becky;
    • Ann Karam, Mary;
    • Reed, Janice;
    • Hamilton, Kimberly;
    • Waksman, Joel;
    • Bruening, Kellie;
    • Srkalovic, Gordan;
    • Andresen, Steven;
    • Kalaycio, Matthew;
    • Sweetenham, John W.;
    • Sobecks, Ronald;
    • Dean, Robert;
    • Knight, Robert;
    • Zeldis, Jerome B.;
    • Baz, Rachid
    Publication type:
    Article
    13
    14

    Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 399, doi. 10.1002/ajh.23653
    By:
    • Pilorge, Sylvain;
    • Rigaudeau, Sophie;
    • Rabian, Florence;
    • Sarkozy, Clémentine;
    • Taksin, Anne L.;
    • Farhat, Hassan;
    • Merabet, Fathia;
    • Ghez, Stéphanie;
    • Raggueneau, Victoria;
    • Terré, Christine;
    • Garcia, Isabelle;
    • Renneville, Aline;
    • Preudhomme, Claude;
    • Castaigne, Sylvie;
    • Rousselot, Philippe
    Publication type:
    Article
    15
    16
    17

    Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 355, doi. 10.1002/ajh.23641
    By:
    • Morabito, Fortunato;
    • Bringhen, Sara;
    • Larocca, Alessandra;
    • Wijermans, Pierre;
    • Victoria Mateos, Maria;
    • Gimsing, Peter;
    • Mazzone, Carla;
    • Gottardi, Daniela;
    • Omedè, Paola;
    • Zweegman, Sonja;
    • José Lahuerta, Juan;
    • Zambello, Renato;
    • Musto, Pellegrino;
    • Magarotto, Valeria;
    • Schaafsma, Martijn;
    • Oriol, Albert;
    • Juliusson, Gunnar;
    • Cerrato, Chiara;
    • Catalano, Lucio;
    • Gentile, Massimo
    Publication type:
    Article
    18
    19

    Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 363, doi. 10.1002/ajh.23640
    By:
    • Minden, Mark D.;
    • Hogge, Donna E.;
    • Weir, Scott J.;
    • Kasper, Jim;
    • Webster, Debra A.;
    • Patton, Lavonne;
    • Jitkova, Yulia;
    • Hurren, Rose;
    • Gronda, Marcela;
    • Goard, Carolyn A.;
    • Rajewski, Lian G.;
    • Haslam, John L.;
    • Heppert, Kathleen E.;
    • Schorno, Kevin;
    • Chang, Hong;
    • Brandwein, Joseph M.;
    • Gupta, Vikas;
    • Schuh, Andre C.;
    • Trudel, Suzanne;
    • Yee, Karen W. L.
    Publication type:
    Article
    20

    Azurophilic granules in myeloma cells.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 437, doi. 10.1002/ajh.23651
    By:
    • Bain, Barbara J.;
    • Siow, Wenchee;
    • Rahemtulla, Amin;
    • Abdalla, Saad
    Publication type:
    Article
    21

    Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 395, doi. 10.1002/ajh.23655
    By:
    • Jabbour, Elias;
    • Daver, Naval;
    • Champlin, Richard;
    • Mathisen, Michael;
    • Oran, Betul;
    • Ciurea, Stefan;
    • Khouri, Issa;
    • Cornelison, A Megan;
    • Ghanem, Hady;
    • Cardenas- Turanzas, Marylou;
    • Popat, Uday;
    • Ravandi, Farhad;
    • Giralt, Sergio;
    • Garcia-Manero, Guillermo;
    • Cortes, Jorge;
    • Kantarjian, Hagop;
    • Lima, Marcos
    Publication type:
    Article
    22